A citation-based method for searching scientific literature

Luis E Almaguer-Mederos, Ilbedis Pérez-Ávila, Raúl Aguilera-Rodríguez, Maria Velázquez-Garcés, Dennis Almaguer-Gotay, Ricardo Hechavarría-Pupo, Annelié Rodríguez-Estupiñán, Georg Auburger. Mov Disord 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Long non-coding RNA MALAT1 regulates cell proliferation and apoptosis via miR-135b-5p/GPNMB axis in Parkinson's disease cell model.
Kefeng Lv, Yuhua Liu, Yanbing Zheng, Shaowen Dai, Peifeng Yin, Haifeng Miao. Biol Res 2021
1
100

Metabolomics of sebum reveals lipid dysregulation in Parkinson's disease.
Eleanor Sinclair, Drupad K Trivedi, Depanjan Sarkar, Caitlin Walton-Doyle, Joy Milne, Tilo Kunath, Anouk M Rijs, Rob M A de Bie, Royston Goodacre, Monty Silverdale,[...]. Nat Commun 2021
8
50

Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.
Penelope G Foulds, J Douglas Mitchell, Angela Parker, Roisin Turner, Gerwyn Green, Peter Diggle, Masato Hasegawa, Mark Taylor, David Mann, David Allsop. FASEB J 2011
117
50

Differentially Expressed Circular RNAs in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease.
Stylianos Ravanidis, Anastasia Bougea, Dimitra Karampatsi, Nikolaos Papagiannakis, Matina Maniati, Leonidas Stefanis, Epaminondas Doxakis. Mov Disord 2021
6
50


The path linking disease severity and cognitive function with quality of life in Parkinson's disease: the mediating effect of activities of daily living and depression.
Yao He, Yuling Tian, Hongjuan Han, Jing Cui, Xiaoyan Ge, Yao Qin, Yanhong Luo, Wenlin Bai, Hongmei Yu. Health Qual Life Outcomes 2021
1
100

Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples.
Lei Chen, Junxiu Yang, Jinhui Lü, Shanshan Cao, Qian Zhao, Zuoren Yu. Brain Behav 2018
36
50

A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers.
Paola Piscopo, Maria Bellenghi, Valeria Manzini, Alessio Crestini, Giada Pontecorvi, Massimo Corbo, Elena Ortona, Alessandra Carè, Annamaria Confaloni. Int J Mol Sci 2021
4
50

Genetic Analysis of ZNF Protein Family Members for Early-Onset Parkinson's Disease in Chinese Population.
Chun Yu Li, Ru Wei Ou, Yong Ping Chen, Xiao Jing Gu, Qian Qian Wei, Bei Cao, Ling Yu Zhang, Yan Bing Hou, Kun Cheng Liu, Xue Ping Chen,[...]. Mol Neurobiol 2021
1
100

Association of the Plasma Long Non-coding RNA MEG3 With Parkinson's Disease.
Yi Quan, Jia Wang, Shuo Wang, Jizong Zhao. Front Neurol 2020
3
50


Towards optimising experimental quantification of persistent pain in Parkinson's disease using psychophysical testing.
Kirsty Bannister, Rory V Smith, Patrick Wilkins, Tatum M Cummins. NPJ Parkinsons Dis 2021
3
50

Sleep disturbance in movement disorders: insights, treatments and challenges.
Grace A Bailey, Emily K Hubbard, Alfonso Fasano, Marina Aj Tijssen, Timothy Lynch, Kirstie N Anderson, Kathryn J Peall. J Neurol Neurosurg Psychiatry 2021
1
100

Parkinson's Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature.
Biswadeep Das, Sriya Priyadarshini Dash, Swabhiman Mohanty, Paritosh Patel. Adv Exp Med Biol 2021
2
50

Bone-Derived Factors as Potential Biomarkers for Parkinson's Disease.
Yuwan Lin, Miaomiao Zhou, Wei Dai, Wenyuan Guo, Jiewen Qiu, Zhiling Zhang, Mingshu Mo, Liuyan Ding, Panghai Ye, Yijuan Wu,[...]. Front Aging Neurosci 2021
1
100

Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Jie Lin, Dongping Cai, Wei Li, Ting Yu, Hui Mao, Shan Jiang, Bin Xiao. Clin Biochem 2019
34
50

Peripheral markers in neurodegenerative patients and their first-degree relatives.
Diana Olga Cristalli, Nathalie Arnal, Fernando Ariel Marra, María J T de Alaniz, Carlos Alberto Marra. J Neurol Sci 2012
60
50

Circular RNAs in Clear Cell Renal Cell Carcinoma: Their Microarray-Based Identification, Analytical Validation, and Potential Use in a Clinico-Genomic Model to Improve Prognostic Accuracy.
Antonia Franz, Bernhard Ralla, Sabine Weickmann, Monika Jung, Hannah Rochow, Carsten Stephan, Andreas Erbersdobler, Ergin Kilic, Annika Fendler, Klaus Jung. Cancers (Basel) 2019
18
50

A Signature of Five Long Non-Coding RNAs for Predicting the Prognosis of Alzheimer's Disease Based on Competing Endogenous RNA Networks.
Cai Huaying, Jin Xing, Jin Luya, Ni Linhui, Sun Di, Ding Xianjun. Front Aging Neurosci 2021
3
50

Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson's disease.
Qiang Li, Zihao Wang, Hao Xing, Yu Wang, Yi Guo. Mol Ther Nucleic Acids 2021
6
50

Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson's Disease.
Yimin Yang, Yanhua Li, Hongmei Yang, Jianxing Guo, Nan Li. Front Mol Neurosci 2021
2
50

Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection.
Yao Wei, Ming Lu, Meng Mei, Haoran Wang, Zhitao Han, Miaomiao Chen, Hang Yao, Nanshan Song, Xiao Ding, Jianhua Ding,[...]. Nat Commun 2020
19
50

Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease.
Xiaochen Bai, Yilin Tang, Mei Yu, Lei Wu, Fengtao Liu, Jianliang Ni, Zishan Wang, Jinghui Wang, Jian Fei, Wei Wang,[...]. Sci Rep 2017
41
50

Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study.
Anelyssa D'Abreu, Marcondes C França, Clarissa L Yasuda, Bruno A G Campos, Iscia Lopes-Cendes, Fernando Cendes. J Neuroimaging 2012
55
50

Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.
Hayley S McLoughlin, Lauren R Moore, Ravi Chopra, Robert Komlo, Megan McKenzie, Kate G Blumenstein, Hien Zhao, Holly B Kordasiewicz, Vikram G Shakkottai, Henry L Paulson. Ann Neurol 2018
62
50

Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice.
Carlo Wilke, Eva Haas, Kathrin Reetz, Jennifer Faber, Hector Garcia-Moreno, Magda M Santana, Bart van de Warrenburg, Holger Hengel, Manuela Lima, Alessandro Filla,[...]. EMBO Mol Med 2020
15
50

Consensus Paper. Cerebellar Reserve: From Cerebellar Physiology to Cerebellar Disorders.
H Mitoma, A Buffo, F Gelfo, X Guell, E Fucà, S Kakei, J Lee, M Manto, L Petrosini, A G Shaikh,[...]. Cerebellum 2020
25
50

Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes.
Isaac M Adanyeguh, Vincent Perlbarg, Pierre-Gilles Henry, Daisy Rinaldi, Elodie Petit, Romain Valabregue, Alexis Brice, Alexandra Durr, Fanny Mochel. Neuroimage Clin 2018
38
50

Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel-Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3.
David D Bushart, Annie J Zalon, Hongjiu Zhang, Logan M Morrison, Yuanfang Guan, Henry L Paulson, Vikram G Shakkottai, Hayley S McLoughlin. Cerebellum 2021
3
50


Prodromal Spinocerebellar Ataxia Type 2 Subjects Have Quantifiable Gait and Postural Sway Deficits.
Luis Velázquez-Pérez, Roberto Rodriguez-Labrada, Yasmani González-Garcés, Eduardo Arrufat-Pie, Reidenis Torres-Vega, Jacqueline Medrano-Montero, Beatriz Ramirez-Bautista, Yaimeé Vazquez-Mojena, Georg Auburger, Fay Horak,[...]. Mov Disord 2021
5
50


Neurofilaments as biomarkers in neurological disorders.
Michael Khalil, Charlotte E Teunissen, Markus Otto, Fredrik Piehl, Maria Pia Sormani, Thomas Gattringer, Christian Barro, Ludwig Kappos, Manuel Comabella, Franz Fazekas,[...]. Nat Rev Neurol 2018
461
50

An approach to studying the neural correlates of reserve.
Yaakov Stern. Brain Imaging Behav 2017
63
50

Free-Living Motor Activity Monitoring in Ataxia-Telangiectasia.
Nergis C Khan, Vineet Pandey, Krzysztof Z Gajos, Anoopum S Gupta. Cerebellum 2021
1
100

Psychosis in Machado-Joseph Disease: Clinical Correlates, Pathophysiological Discussion, and Functional Brain Imaging. Expanding the Cerebellar Cognitive Affective Syndrome.
Pedro Braga-Neto, José Luiz Pedroso, Ary Gadelha, Maura Regina Laureano, Cristiano de Souza Noto, Griselda Jara Garrido, Orlando Graziani Povoas Barsottini. Cerebellum 2016
6
50

Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia.
H Donath, S Woelke, R Schubert, M Kieslich, M Theis, G Auburger, R P Duecker, S Zielen. Cerebellum 2021
2
50

Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease.
E C Etchebehere, F Cendes, I Lopes-Cendes, J A Pereira, M C Lima, C R Sansana, C A Silva, M F Camargo, A O Santos, C D Ramos,[...]. Arch Neurol 2001
35
50

Quality of Life since Pre-Ataxic Phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Gabriela Bolzan, Vanessa Bielefeldt Leotti, Camila Maria de Oliveira, Gabriela Ecco, Amanda Henz Cappelli, Anastacia Guimarães Rocha, Nathalia Kersting, Mariana Rieck, Lucas Schenatto de Sena, Ana Carolina Martins,[...]. Cerebellum 2021
1
100

Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
Jörg B Schulz, Johannes Borkert, Stefanie Wolf, Tanja Schmitz-Hübsch, Maryla Rakowicz, Caterina Mariotti, Ludger Schöls, Dagmar Timmann, Bart van de Warrenburg, Alexandra Dürr,[...]. Neuroimage 2010
110
50

Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.
Sarah Doss, Alexander U Brandt, Timm Oberwahrenbrock, Matthias Endres, Friedemann Paul, Jan Leo Rinnenthal. Cerebellum 2014
9
50

Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3.
Mercedes Prudencio, Hector Garcia-Moreno, Karen R Jansen-West, Rana Hanna Al-Shaikh, Tania F Gendron, Michael G Heckman, Matthew R Spiegel, Yari Carlomagno, Lillian M Daughrity, Yuping Song,[...]. Sci Transl Med 2020
7
50

Static and Dynamic Ocular Motor Abnormalities as Potential Biomarkers in Spinocerebellar Ataxia Type 3.
João Lemos, Ana Novo, Cristina Duque, Inês Cunha, Joana Ribeiro, João Castelhano, Cristina Januário. Cerebellum 2021
1
100


Immune-mediated cerebellar ataxias: from bench to bedside.
Hiroshi Mitoma, Mario Manto, Christiane S Hampe. Cerebellum Ataxias 2017
20
50

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Adriano M de Assis, Jonas Alex Morales Saute, Aline Longoni, Clarissa Branco Haas, Vitor Rocco Torrez, Andressa Wigner Brochier, Gabriele Nunes Souza, Gabriel Vasata Furtado, Tailise Conte Gheno, Aline Russo,[...]. Front Neurol 2017
30
50

Neuroradiological Findings in the Spinocerebellar Ataxias.
Alex Tiburtino Meira, Walter Oleschko Arruda, Sergio Eiji Ono, Arnolfo de Carvalho Neto, Salmo Raskin, Carlos Henrique F Camargo, Hélio Afonso G Teive. Tremor Other Hyperkinet Mov (N Y) 2019
12
50

Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches.
Luis C Velázquez-Pérez, Roberto Rodríguez-Labrada, Juan Fernandez-Ruiz. Front Neurol 2017
38
50

Functional Changes of Mentalizing Network in SCA2 Patients: Novel Insights into Understanding the Social Cerebellum.
Giusy Olivito, L Siciliano, S Clausi, M Lupo, S Romano, M Masciullo, M Molinari, M Cercignani, M Bozzali, M Leggio. Cerebellum 2020
5
50

Association of serum neurofilament light and disease severity in patients with spinocerebellar ataxia type 3.
Yun Peng, Youming Zhang, Zhao Chen, Huirong Peng, Na Wan, Jennifer Zhang, Jingyi Tang, Puzhi Wang, Yue Xie, Qiyong Cai,[...]. Neurology 2020
3
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.